共 50 条
- [34] Extended induction response in patients treated with mirikizumab with moderately to severely active ulcerative colitis in the LUCENT trials JOURNAL OF CROHNS & COLITIS, 2023, 17 : 682 - 682
- [35] Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis Digestive Diseases and Sciences, 2023, 68 : 2318 - 2332
- [37] The efficacy and safety of guselkumab induction therapy in patients with moderately to severely active Ulcerative Colitis: Phase 2b QUASAR Study results through week 12 JOURNAL OF CROHNS & COLITIS, 2022, 16 : I025 - I026
- [38] ECCO Grant Immune-epithelial crosstalk boosting intestinal repair in ulcerative colitis JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2258 - I2258
- [40] Tofacitinib Has Induction Efficacy in Moderately to Severely Active Ulcerative Colitis, Regardless of Prior TNF Inhibitor Therapy AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S261 - S261